SolGel Technologies (SLGL)
(Delayed Data from NSDQ)
$0.65 USD
-0.05 (-7.04%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $0.65 0.00 (0.62%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SLGL 0.65 -0.05(-7.04%)
Will SLGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLGL
Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
SLGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
Bausch Health (BHC) Beats Q2 Earnings and Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
Other News for SLGL
Biotech Alert: Searches spiking for these stocks today
Raymond James gets more bearish on Sol-Gel Technologies, downgrades shares
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Sol-Gel Technologies GAAP EPS of $0.07 beats by $0.26, revenue of $5.43M beats by $3.82M
Sol-Gel Technologies GAAP EPS of -$0.22 misses by $0.03, revenue of $0.59M misses by $1.02M